Vertex Pharma - VRTX - stock price prediction, stock price target, analyst ratings from 33 analysts

Vertex Pharma has a share price target of US$ 549, revenue growth forecast of 8.6%, and profit growth estimate of 12.6% for FY26, based on top 33 analyst calls.